📈 Price History

Ratio Health

— Excellent

— Good

— Average

— Poor

By Category

📊 Sector Averages

About

Spectrum Brands Holdings, Inc. operates as a branded consumer products and home essentials company in North America, Europe, the Middle East, Africa, Latin America, and Asia-Pacific regions. The company operates through three segments: Home and Personal Care (HPC); Global Pet Care (GPC); and Home and Garden (H&G). The Home and Personal Care segment provides home appliances under the Black & Decker, Russell Hobbs, George Foreman, PowerXL, Emeril Legasse, Copper Chef, Juiceman, and Breadman brands; and personal care products under the Remington brand. The GPC segment provides Rawhide chews, dog and cat clean-up, training, health and grooming products, small animal food and care products, rawhide-free dog and cat treats, and wet and dry pet food for dogs and cats under the Good'n'Fun, DreamBone, Good Boy, SmartBones, IAMS, EUKANUBA, Nature's Miracle, FURminator, Dingo, 8IN1, Better Belly, Meowee!, and Wild Harvest brands. This segment also offers aquarium kits, stand-alone tanks, and aquatics equipment and consumables under the Tetra, Marineland, Instant Ocean, GloFish, and OmegaSea brands. The H&G segment provides outdoor insect and weed control solutions, and animal repellents under the Spectracide, Garden Safe, Liquid Fence, and EcoLogic brands; household pest control solutions under the Hot Shot and Black Flag brands; household surface cleaning, maintenance, and restoration products, including bottled liquids, mops, wipes, and markers under the Rejuvenate brand; and personal-use pesticides and insect repellent products under the Cutter and Repel brands. It sells its products through retailers, e-commerce and online retailers, wholesalers, and distributors. Spectrum Brands Holdings, Inc. was founded in 1906 and is based in Middleton, Wisconsin.

Key Ratios Snapshot

📈 Growth Pattern

⚡ Latest Quarter —

See full financials →

📊 Quick Scorecard

Loading…

🔍 Concall Decoded

🎙 Management Tone Tracker Mixed ↓ Deteriorating 3 quarters analysed

Q4 2025

Confident Specific

Management repeatedly stated that the worst of tariff and economic disruptions are behind them, provided specific free cash flow ($170.7M), net leverage (1.58x), and share repurchase (4.4M shares) figures, and gave clear guidance for fiscal 2026 growth in Global Pet Care and Home & Garden. They acknowledged a challenging year but expressed optimism about future performance.

Q1 2026

Confident Specific

Management used language like 'strategy is working', 'exceeded expectations', 'we are pleased' and cited concrete numbers ($60M free cash flow, 800k shares repurchased, 1.65x leverage), while acknowledging remaining headwinds in HPC and timing of garden recovery.

Q2 2026 latest

Mixed

Management expressed confidence with phrases like 'another strong quarter', 'outperformed expectations', and 'impressive 17.8% growth', but also tempered with caution: 'cautious about the resilience of the consumer', 'remain vigilant', and 'mindful of geopolitical tensions'.

Guidance Reliability Pending · <3Q data

Investor Lens

The investment thesis is stronger after this call: SPB delivered its first year-over-year growth since Q1 2025, with pet and H&G gaining share and expanding margins. The Oaktree partnership provides a clear path to separate HPC and unlock value. However, management remains cautious on consumer softness and macro risks (tariffs, Middle East). Next quarter should show whether pet and H&G momentum can be sustained without pull-forward benefits, and whether HPC EBITDA continues to improve despite top-line decline. The strong balance sheet and buyback capacity add downside protection.

AI-generated concall tone analysis · Updated 2026-06-09 · Not investment advice

🎙 Management Tone Mixed ↓ Deteriorating 3 quarters Full tone analysis in Intelligence →

📊 MIXED Spectrum Brands Q2 2026: Net sales +4.9%, adj. EBITDA +17.8%, Oaktree partnership for HPC.

Revenue & Profitability

Q2 2026 net sales increased 4.9% (organic +1.5%), gross margin improved 60 bps to 38.1%, operating income rose to $43.5 million (up $24 million), and adjusted EBITDA grew 17.8% to $84 million. GAAP diluted EPS increased due to higher operating income and lower share count, with adjusted diluted EPS of $1.25. The company ended the quarter with $125.1 million cash, net debt of $474.6 million, and net leverage of 1.66x.

Outlook

Management sees signs of stabilization but remains cautious due to geopolitical tensions (Middle East conflict), rising global fuel prices, and potential U.S. trade policy volatility. Consumer demand is generally resilient except for softness in HPC. For H&G, favorable weather trends support a strong season start, but weather uncertainty persists. Full-year net sales are expected flat to up low single digits, with adjusted EBITDA growth raised to low-to-mid single digits.

Growth Drivers

Growth is driven by innovation and market share gains in GPC (DreamBone CollaYUMS, Nature's Miracle) and H&G (Spectracide fertilizer, Cutter repellents). E-commerce in GPC achieved double-digit growth. LATAM HPC grew mid-single digits organically. The 'Fewer, Bigger, Better' strategy focuses resources on high-impact brands, and a new price pack architecture in pet aims to improve category health. The Oaktree partnership for HPC creates optionality for future separation or M&A.

Balance Sheet & CapEx

Capital expenditures were $9.3 million in Q2, roughly flat YoY. Full-year 2026 CapEx guidance is $50–60 million. Investments are focused on the S/4HANA ERP transformation, with recent deployment on GPC EMEA, and continued brand innovation and marketing support. Cash payments for restructuring and strategic transactions are expected to be $25–35 million for the year.

Margins

Gross margin improved 60 bps to 38.1% in Q2, driven by pricing, cost actions, and favorable FX, partially offset by higher trade spend and tariffs. Adjusted EBITDA margin expanded in both GPC (19.0% vs. 18.6%) and H&G (20.5% vs. 17.5%). HPC saw margin improvement (3.4% vs. 2.9%) despite lower sales. Full-year adjusted EBITDA margin is expected to grow low-to-mid single digits, supported by productivity gains and expense management.

Key Risks

Management flagged risks including geopolitical tensions (Middle East conflict), global fuel prices, U.S. trade policy volatility, and consumer demand softness in HPC. Tariff costs are expected to be largely offset through pricing and actions, but no refund benefits are factored into guidance. Weather uncertainty for H&G and potential disruption from the S/4HANA transition are also noted. The company maintains cautious inventory management given macro headwinds.

Generated by AI · Q2 2026 results · Not investment advice

✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter

🔍

🔎 See cross-company document search → ?

📞 Earnings Call Transcripts (5)

Q3 2026 Q3 2026 2026-08-07

Net sales rose 7.7% year-over-year, with all business units growing and Home & Garden achieving record results. Adjusted EBITDA increased 27.5% (excluding tariff refunds), and guidance was raised for full-year EBITDA growth. Strategic priorities include operational excellence, innovation, and disciplined capital allocation.

Q2 2026 Q2 2026 2026-05-07

Net sales rose 4.9% and adjusted EBITDA grew 17.8% year-over-year, driven by strong Global Pet Care and Home & Garden performance, while Home & Personal Care declined in sales but improved profitability. Fiscal 2026 guidance was raised for adjusted EBITDA, with continued caution on macro risks.

Q1 2026 Q1 2026 2026-02-05

Q1 2026 results exceeded expectations despite net sales and EBITDA declines, driven by strong performance in Global Pet Care and disciplined capital allocation. Guidance for fiscal 2026 is reiterated, with growth expected in Pet Care and Home and Garden, while Home and Personal Care remains challenged.

Q4 2025 Q4 2025 2025-11-13

Fiscal 2025 saw a 5.2% sales decline amid macro and tariff headwinds, but strong cost controls and supply chain actions drove $171M in free cash flow, exceeding targets. Global Pet Care and Home & Garden are set to return to growth in 2026, while Home & Personal Care remains challenged.

Q3 2025 Q3 2025 2025-08-07

Q3 results were heavily impacted by tariff disruptions, leading to an 11.1% organic sales decline and $30 million in lost sales, though cost reductions and resumed shipments have driven a strong July rebound. Free cash flow guidance of $160 million is reaffirmed, with ongoing supply chain diversification and disciplined capital allocation.

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯

Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.

📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.